Upregulating immune checkpoint LILRB4 to induce immune evasion and decitabine resistance;further to support tumor cell infiltration into tissues and suppress T cell activity via a signaling pathway that involves APOE, LILRB4, SHP-2, uPAR and ARG1 in acute myeloid leukemia cells. This evidence concerns the gene LILRB4 and neoplasm.